Intensity Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
/PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS), a clinical-stage biotechnology company focused on the discovery and development of proprietary,...
Source: prnewswire.com